(19)
(11) EP 4 798 212 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24820796.1

(22) Date of filing: 28.11.2024
(51) International Patent Classification (IPC): 
A61K 31/7076(2006.01)
C07H 19/00(2006.01)
A61P 35/00(2006.01)
A61K 39/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/7076; A61P 35/00; C07H 19/167
(86) International application number:
PCT/GB2024/052991
(87) International publication number:
WO 2025/114712 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.11.2023 GB 202318158

(71) Applicant: University of Surrey
Guildford, Surrey GU2 7XH (GB)

(72) Inventors:
  • ASIM, Mohammad
    Guildford Surrey GU2 7WG (GB)
  • GALEANO-DALMAU, Nuria
    Cambridge Cambridgeshire CB2 0AA (GB)
  • SPRING, David
    Cambridge Cambridgeshire CB2 1EW (GB)
  • KANDEMIR, Jiyan
    Cambridge Cambridgeshire CB2 1EW (GB)

(74) Representative: Hutter, Anton 
Venner Shipley LLP 5 Stirling House Stirling Road The Surrey Research Park
Guildford GU2 7RF
Guildford GU2 7RF (GB)

   


(54) ADENOSINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER